The authorised nuclear medicine site has the following equipment: 1° An emergency trolley for the treatment of patients requiring it; 2° Equipment for waste and effluent management in accordance with the provisions of article R. 1333-12.
I.-The holder of the “A” authorisation pursuant to Article R. 6123-135 shall have a team comprising: 1° At least one doctor specialising in nuclear medicine present on site during patient care; 2° At least one medical electroradiology technician present on site during patient care; 3° At least one doctor authorised to carry out stress tests present on site during stress tests. The holder of the authorisation must ensure that a…
The role of the radiopharmacist provided for in article D. 6124-189 is to ensure the safety of the radiopharmaceutical medicine circuit and includes in particular: 1° Carrying out control actions relating to the preparation and holding conditions of these medicines; 2° The supply of medicines, products and objects mentioned in article L. 4211-1 and sterile medical devices. The radiopharmacist participates in the development and implementation of the quality process in…
Staff working in the delimited area where radiopharmaceutical preparations and controls are carried out receive appropriate initial and ongoing training in radiopharmacy and radiation protection for staff, patients, the public and the environment.
The equipment on the site authorised under the conditions of Article R. 6123-136 is connected to a system for archiving and sharing images and to a system for archiving and analysing doses. The report given to the patient specifies the dosimetric data concerning him or her.
The authorisation holder is subject to the obligation of quality assurance defined in I of Article L. 1333-19.
The provisions of paragraph 1 of sub-section 9, with the exception of those of II of article D. 6124-131, are applicable to the holder of a nuclear medicine qualification with grade B when carrying out therapeutic cancer procedures involving the administration of radiopharmaceuticals.
The provisions of this paragraph apply to any holder of a home hospital care authorisation, regardless of the category, subject to the specific provisions for each category defined in this sub-section.
The general organisation, the staff, the nature and location of the premises and the equipment of the holder of the home hospital care authorisation are adapted to the volume of activity and the nature of the care provided and enable it to carry out its tasks throughout the geographical area defined in III of Article R. 6123-140.
The holder of the home hospital care authorisation has a remote communication system to ensure a permanent link between patients, their relatives and the home hospital care structure. It also has a computerised patient file and an information system guaranteeing access to it by the members of the multidisciplinary team mentioned in Article D. 6124-197.
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.
